Skip to main content

Endo Stock Surges 17% Following Settlement Agreement

Endo Stock

Endo International plc (NASDAQ:ENDP) has agreed to pay a $10 million USD settlement in a landmark opioid case, boosting Endo stock 17%.

Fueling the Opioid Crisis?

The settlement stems from a lawsuit brought against Endo International and fellow drug manufacturer Allergan plc (NYSE:AGN), by two Ohio counties that have accused various drug manufacturers from fueling the US opioid crisis. Both companies were due to go to trial in October, but have now avoided that court date following today’s settlement. Endo confirmed that it will pay $10 million USD in damages to the counties of Cuyahoga and ...

Read The Full Article On MicroSmallCap.com

Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.

All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.